SkinbiotherapeuticsSBTX 
$0.13-0.94%24h
-0.94%24h
Global rank
Market cap$21.67M
Change 7d-14.95%
YTD Performance-30.98%
SP500 benchmarkUnderperform
P/E-7.65
P/S131.28
Revenue$165.04K
Earnings-$3.54M
Dividend yield-
Main Sector
Healthcare
Category
Skinbiotherapeutics (SBTX) Net Assets
SBTX Net Assets in 2023: $1.99M
As of 20 Dec 2024, Skinbiotherapeutics net assets is $1.99M, an decrease of -19.41% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Skinbiotherapeutics overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
Skinbiotherapeutics Net Assets History from 2019 to 2024
-
Value:-
SBTX Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $1.99M | -19.41% |
| 2022 | $2.48M | -52.54% |
| 2021 | $5.22M | 111.50% |
| 2020 | $2.47M | -281.12% |
| 2019 | $-1.36M | - |
View the Top Net Assets Companies
